StonvexLoading…
StonvexStonvexStonvexCore line items from ASRT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $118.71M | $124.96M | $152.07M | $156.23M |
Operating Income | $-21.54M | $-24.48M | $-243.54M | $39.41M |
Net Income | $-30.38M | $-21.58M | $-331.94M | $109.63M |
EPS (Diluted) | $-4.74 | $-3.40 | $-4.67 | $2.03 |
Total Assets | $266.97M | $284.73M | $286.42M | $413.91M |
Total Liabilities | $173.02M | $163.65M | $148.42M | $188.19M |
Cash & Equivalents | $10.23M | $50.59M | $73.44M | $64.94M |
Free Cash Flow OCF − CapEx | Not available | $26.41M | $48.98M | $78.32M |
Shares Outstanding | 6.42M | 6.37M | 94.67M | 48.32M |